Results 101 to 110 of about 15,050 (215)

Increased choroidal stromal volume and altered choriocapillaris perfusion in neovascular AMD: An SS-OCTA association study

open access: yesPhotodiagnosis and Photodynamic Therapy
Purpose: This study aimed to characterize quantitative choroidal metrics using swept-source optical coherence tomography angiography (SS-OCTA) across different stages associated with neovascular age-related macular degeneration (nAMD) and to identify ...
Xuelin Chen   +9 more
doaj   +1 more source

Recent daily life burdens associated with neovascular age-related macular degeneration involve difficulties in use of electronic devices

open access: yesScientific Reports
Neovascular age-related macular degeneration (nAMD) is a prevalent cause of permanent vision loss and blindness in the elderly worldwide, with a significant impact on patients’ daily lives.
Yoko Ozawa   +7 more
doaj   +1 more source

Systemic oxidative stress levels and their associations with the risk of neovascular age-related macular degeneration and treatment response

open access: yesInternational Journal of Retina and Vitreous
Purpose To investigate the association between oxidative stress (OS) and both the risk of neovascular age-related macular degeneration (nAMD) and the treatment response to intravitreal anti-vascular endothelial growth factor injections (anti-VEGF IVIs ...
Maiko Abe   +6 more
doaj   +1 more source

Faricimab bei vorbehandelter neovaskulärer altersabhängiger Makuladegeneration (nAMD)

open access: yesDie Ophthalmologie
Zusammenfassung Hintergrund Faricimab wurde als erster bispezifischer Antikörper 9/2022 zur Behandlung der neovaskulären altersabhängigen Makuladegeneration (nAMD) und einer Visusbeeinträchtigung infolge eines diabetischen Makulaödems oder eines retinalen Venenverschlusses in der EU zugelassen.
Britta Heimes-Bussmann   +9 more
openaire   +1 more source

Technik und Strategie der adjuvanten Radiotherapie bei nAMD

open access: yes, 2017
Hintergrund: In der Therapie der neovaskulären altersabhängigen Makuladegeneration (nAMD) sind intravitreale VEGF-Inhibitoren die Therapie der ersten Wahl. Die Verbesserung der Prognose der AMD erfordert jedoch viele intraokulare Injektionen. Die theoretische Grundlage für eine mögliche[zum vollständigen Text gelangen Sie über die oben angegebene URL]
Rating, P, Freimuth, MA, Bornfeld, N
openaire   +2 more sources

Advancing nonadiabatic molecular dynamics simulations in solids with E(3) equivariant deep neural hamiltonians

open access: yesNature Communications
Non-adiabatic molecular dynamics (NAMD) simulations have become an indispensable tool for investigating excited-state dynamics in solids. In this work, we propose a general framework, N2AMD (Neural-Network Non-Adiabatic Molecular Dynamics), which employs
Changwei Zhang   +9 more
doaj   +1 more source

Cataract Surgery in nAMD Patients Receiving Intravitreal Aflibercept Injections

open access: yesJournal of Clinical Medicine
Background: To evaluate functional and anatomical outcomesof cataract surgery in neovascular age-related macular neovascularization (nAMD) eyes receiving anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections in modified pro re nata (PRN) regimen. Materials and Methods: Sixty eyes of 60 nAMD patients, including 41 women (68.3%) and
Małgorzata Seredyka-Burduk   +4 more
openaire   +2 more sources

A Novel Optometry-Led Decision-Making Community Referral Refinement Scheme for Neovascular Age-Related Macular Degeneration Screening

open access: yesClinical Optometry
Francis WB Sanders,1 Rebecca John,2 Philip Jones,3 Gwyn Samuel Williams1 1Department of Ophthalmology, Singleton Hospital, Swansea, UK; 2Primary Care Services, NHS Wales Shared Services Partnership, Cardiff, UK; 3Optometry Division, Specsavers Opticians,
Sanders FW, John R, Jones P, Williams GS
doaj  

Faricimab in the Treatment of Exudative Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Italy: The FARIT Real World Study

open access: yesOphthalmology and Therapy
Introduction Faricimab is a bispecific antibody that enables greater disease control and extended durability compared with vascular endothelial growth factor (VEGF) inhibition alone in neovascular age-related macular degeneration (nAMD) and diabetic ...
Marco Lupidi   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy